Caricamento...
Attitudes of Individuals with Gaucher Disease toward Substrate Reduction Therapies
Type 1 Gaucher disease (GD) is the most common lysosomal storage disorder. Previously, treatment for GD was limited to intravenous enzyme replacement therapies (ERTs). More recently, oral substrate reduction therapies (SRTs) were approved for treatment of GD. Although both therapies alleviate diseas...
Salvato in:
| Pubblicato in: | J Genet Couns |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer US
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5794801/ https://ncbi.nlm.nih.gov/pubmed/28803392 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10897-017-0137-0 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|